Venetoclax Therapy in Chronic Lymphocytic Leukemia Patients Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation

被引：0
|
作者：
Perutelli, Francesca [1 ]
Boccellato, Elia [1 ]
Catania, Gioacchino
Frustaci, Anna Maria [3 ]
Innocenti, Idanna [4 ]
Moia, Riccardo [5 ]
Quaresmini, Giulia [6 ]
Gaidano, Gianluca [5 ]
Ladetto, Marco [2 ]
Laurenti, Luca [7 ]
Rambaldi, Alessandro [6 ]
Tedeschi, Alessandra [3 ]
Bruno, Benedetto [1 ]
Vitale, Candida [1 ]
Coscia, Marta [1 ]
机构：
[1] Univ Torino, Univ Div Hematol, AOU Citta Salute & Sci Torino, Turin, Italy
[2] Azienda Osped Santi Antonio Biagio & Cesare Arrig, Div Hematol, Alessandria, Italy
[3] ASST Grande Osped Metropolitano Niguarda, Dept Haematol, Niguarda Canc Ctr, Milan, Italy
[4] Fdn Policlin Univ Gemelli, Sect Hematol, Dept Radiol & Hematol Sci, Rome, Italy
[5] Univ Piemonte Orientale, Dpt Translat Med, Div Hematol, Novara, Italy
[6] ASST Papa Giovanni XXIII, USC Ematol, Bergamo, Italy
[7] Fdn Policlin A Univ Gemelli, Catholic Univ, Sect Hematol, Dept Radiol & Hematol Sci, Rome, Italy
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
CLL; venetoclax; alloHSCT;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CLL-347
引用
收藏
页码：S325 / S326
页数：2
相关论文
共 50 条
  • [1] Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantation
    Perutelli, Francesca
    Boccellato, Elia
    Montalbano, Maria Chiara
    Catania, Gioacchino
    Deodato, Marina
    Frustaci, Anna Maria
    Innocenti, Idanna
    Moia, Riccardo
    Quaglia, Francesca Maria
    Quaresmini, Giulia
    Rivela, Paolo
    Gaidano, Gianluca
    Krampera, Mauro
    Laurenti, Luca
    Rambaldi, Alessandro
    Bruno, Benedetto
    Vitale, Candida
    Coscia, Marta
    BRITISH JOURNAL OF HAEMATOLOGY, 2025, 206 (03) : 924 - 929
  • [2] Venetoclax plus rituximab or obinutuzumab after allogeneic hematopoietic stem cell transplantation in chronic lymphocytic leukemia
    Al-Sawaf, Othman
    Herling, Carmen Diana
    Holtick, Udo
    Scheid, Christoph
    Cramer, Paula
    Sasse, Stephanie
    von Tresckow, Bastian
    Tuchscherer, Armin
    Fischer, Kirsten
    Eichhorst, Barbara
    Hallek, Michael
    Frenzel, Lukas P.
    HAEMATOLOGICA, 2019, 104 (05) : E224 - E226
  • [3] Second allogeneic hematopoietic stem cell transplantation in patients with acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation
    Choi, Yunsuk
    Choi, Eun-Ji
    Lee, Jung-Hee
    Lee, Kyoo-Hyung
    Jo, Jae-Cheol
    Park, Han-Seung
    Lee, Yoo Jin
    Seol, Miee
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Lee, Je-Hwan
    CLINICAL TRANSPLANTATION, 2021, 35 (03)
  • [4] OUTCOMES AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH ADVANCED CHRONIC LYMPHOCYTIC LEUKEMIA
    Rashed, A.
    Corringham, S.
    Castro, J. E.
    Kipps, T. J.
    Ball, E. D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S295 - S295
  • [5] Ibrutinib as salvage therapy for relapsed high-risk chronic lymphocytic leukemia (CLL) in patients after allogeneic hematopoietic stem cell transplantation (HSCT)
    Hahn, M.
    Dietrich, S.
    Goerner, M.
    Welslau, M.
    Zenz, T.
    Rummel, M.
    Schmitt, M.
    Koehler, A.
    Ho, A. D.
    Dreger, P.
    Oncology Research and Treatment, 2015, 38 : 93 - 93
  • [6] Progressive Chronic Lymphocytic Leukemia After Allogeneic Hematopoietic Cell Transplantation
    Jitawatanarat, Potjana
    Desai, Arpita
    Sharda, Pradeep
    Liu, Hong
    Ross, Maureen
    Hernandez-Llizaliturri, Francisco J.
    McCarthy, Philip L.
    Chen, George L.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (10): : 1203 - 1206
  • [7] Efficacy of Venetoclax Combination Therapy with Hypomethylating Agents in Patients with Relapsed Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation
    Mittal, Varun
    Lo, Mimi
    Damon, Lloyd E.
    Gaensler, Karin L.
    Martin, Thomas G., III
    Olin, Rebecca L.
    Smith, Catherine C.
    Logan, Aaron C.
    BLOOD, 2019, 134
  • [8] Economic Evaluation for the US of Venetoclax Versus Allogeneic Hematopoietic Stem-Cell Transplantation for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia with 17p Deletion
    Alsaid, Nimer
    McBride, Ali
    Oh, Mok
    Persky, Daniel
    Anwer, Faiz
    Andritsos, Leslie
    Kumar, Abhijeet
    Yun, Seongseok
    Abraham, Ivo
    BLOOD, 2017, 130
  • [9] Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia
    Michallet, Mauricette
    Sobh, Mohamad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S19 - S20
  • [10] Role of Allogeneic Hematopoietic Stem-Cell Transplantation in Chronic Lymphocytic Leukemia
    Gribben, John G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (30) : 4864 - 4865
12345